CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 8-K Event Material agreement · Other events
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- S-3 Offering Registration Statement
- 10-K/A Report 10-K/A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 41 of 50 · 996 filings